These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Commentary on an abstract. Effects of metoclopramide and domperidone on azygous venous blood flow in patients with cirrhosis and portal hypertension]. Sauerbruch T Z Gastroenterol; 1987 Sep; 25(9):612-3. PubMed ID: 3673147 [No Abstract] [Full Text] [Related]
25. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283 [TBL] [Abstract][Full Text] [Related]
26. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats. Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196 [TBL] [Abstract][Full Text] [Related]
28. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related]
29. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis. Bizer LS Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791 [TBL] [Abstract][Full Text] [Related]
30. [Value of the rheohepatogram in the diagnosis of liver malignancy]. Zheng HR Zhonghua Zhong Liu Za Zhi; 1984 Mar; 6(2):109-11. PubMed ID: 6468249 [No Abstract] [Full Text] [Related]
32. [Radioisotope study of the liver and portal circulation in portal hypertension]. Makhov NI; Soskin AM; Zhigileva VI; Ender LA Khirurgiia (Mosk); 1969 Mar; 45(3):81-7. PubMed ID: 5375959 [No Abstract] [Full Text] [Related]
33. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol]. López Fuerte F; Cárdenas Rojas JA; Esquivel López A; Perches Vega A Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507 [No Abstract] [Full Text] [Related]
34. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters. Gitlin N Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937 [No Abstract] [Full Text] [Related]
35. Propranolol increases arterial ammonia in liver cirrhosis. van Buuren HR; van der Velden PC; Koorevaar G; Silberbusch J Lancet; 1982 Oct; 2(8305):951-2. PubMed ID: 6127460 [TBL] [Abstract][Full Text] [Related]
36. [The effects of propranolol or nitroglycerin on azygos blood flow in patients with portal hypertension]. Notsumata K Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1489-97. PubMed ID: 3097355 [No Abstract] [Full Text] [Related]
37. Treatment options in portal hypertension: Does propranolol have a role? Proceedings of a satellite symposium of the XIII International Congress of Gastroenterology and the VI European Congress of Digestive Endoscopy. Rome, 9 September 1988. Drugs; 1989; 37 Suppl 2():1-73. PubMed ID: 2806132 [No Abstract] [Full Text] [Related]
38. [Comparative value of the rheohepatogram of healthy children, adolescents and adults during expiration and inspiration]. Sarkisian NM; Andreeva NIa Ter Arkh; 1977; 49(6):93-7. PubMed ID: 898056 [No Abstract] [Full Text] [Related]
39. Propranolol for portal hypertension. Dominguez P Lancet; 1981 Jun; 1(8233):1322-3. PubMed ID: 6112641 [No Abstract] [Full Text] [Related]
40. Decreasing hepatic vascular tone by liver-specific NO donors: wishful thinking or a promising reality? Bosch J J Hepatol; 2003 Dec; 39(6):1072-5. PubMed ID: 14642629 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]